News

Check all IrsiCaixa scientific news in just one click.

laboratori

SARS-CoV-2

30/04/2025

A new mouse model allows for more accurate study of COVID-19 in humans

Vaccines

HIV

08/04/2025

IrsiCaixa participates in an $18M international project to develop a preventive HIV vaccine

Achievement

01/04/2025

The principal investigator of IrsiCaixa, Roger Paredes, joins as the medical coordinator of the curriculum for the new Medicine degree at UPC

Visita President Parlament

19/03/2025

President of the Parliament Josep Rull visits IrsiCaixa and the Fight Infections Foundation to support their research

Vaccine HTI

HIV

Vaccines

06/03/2025

Phase II clinical trial AELIX-003 confirms that the immune response to the HTI therapeutic vaccine helps improve HIV control without treatment

Achievement

04/03/2025

30 years of IrsiCaixa: the legacy of past pandemics to face those of the future

Plitidepsina

Emerging pathogens

07/02/2025

Discovering the molecular footprint of a drug: how an anticancer drug can become a solution against multiple viruses

HIV

29/01/2025

Interruption of HIV treatment: a new study guides the design of future clinical trials for an HIV cure

Irene Gonzalez LoViReT

HIV

29/11/2024

The viral reservoir, the main obstacle to eradicating HIV, is up to four times smaller in those who started treatment after 2007